In scientific research and laboratory testing, the terms in vitro and in vivo are widely used to describe different types of experiments. Although they are often mentioned together, they refer to very different research approaches that play complementary roles in science and innovation.<\/p>\n
Understanding the difference between in vitro and in vivo studies<\/strong> is essential in fields such as biotechnology, medicine, food science and pharmaceuticals.<\/p>\n In vitro<\/strong> is a scientific term used to describe experiments performed outside a living organism, usually in a controlled laboratory environment such as test tubes, petri dishes or culture plates.<\/p>\n In vitro experiments allow researchers to study cells, microorganisms or biological molecules in isolation, under highly controlled conditions. This makes it easier to observe specific reactions, test compounds and analyse mechanisms without interference from complex biological systems.<\/p>\n Depending on the study\u2019s objective, different animal models are used:<\/strong><\/p>\n Drosophila melanogaster<\/em> (fruit fly)<\/strong> is widely used in genetic and neurobehavioral research due to its ease of genetic manipulation.<\/p>\n<\/li>\n Danio rerio<\/em> (zebrafish)<\/strong> allows the study of embryonic development, toxicology, and gene function using techniques such as gene editing.<\/p>\n<\/li>\n Rodents (mice and rats),<\/strong> and in more specific studies, non-human primates.<\/strong> These are employed to assess pharmacokinetics, toxicity, or efficacy of new compounds before entering human clinical trials.<\/p>\n<\/li>\n<\/ul>\n Evaluation of the efficacy and toxicity<\/strong> of drugs, bioactive compounds, or functional ingredients.<\/p>\n<\/li>\n Study of disease pathophysiology<\/strong> and progression.<\/p>\n<\/li>\n Behavioral and neurobiological<\/strong> research.<\/p>\n<\/li>\n Biodegradation and toxicity<\/strong> testing in complex chemical environments.<\/p>\n<\/li>\n<\/ul>\n Enables a systemic and integrated analysis<\/strong> of a compound or technology\u2019s effects.<\/p>\n<\/li>\n Offers full physiological relevance<\/strong>, considering all metabolic processes and organic interactions.<\/p>\n<\/li>\n Makes it possible to study chronic, multifactorial, or multi-organ effects.<\/strong><\/p>\n<\/li>\n<\/ul>\n Requires long execution and planning<\/strong> timelines.<\/p>\n<\/li>\n Involves high economic and logistical costs.<\/strong><\/p>\n<\/li>\n Presents significant ethical implications<\/strong>, especially regarding animal use.<\/p>\n<\/li>\n Shows higher interindividual variability<\/strong>, which can hinder interpretation in early research stages.<\/p>\n<\/li>\n<\/ul>\n Although in vivo testing provides a comprehensive view, it is not always the first option<\/strong>. Increasingly, in vitro studies<\/strong> are promoted as a preliminary or alternative step, particularly in exploratory phases, aligned with the 3Rs principle: Replace, Reduce, and Refine the use of animals in research.<\/strong><\/p>\n In vivo<\/strong> refers to studies and experiments conducted inside a living organism, such as animals, plants or humans.<\/p>\n This type of experimentation allows the analysis of specific variables\u2014such as cellular response, compound absorption, or enzymatic activity, without the complexity of a full biological system.<\/p>\n There is also the ex vivo<\/em> approach (\u201coutside the living\u201d)<\/strong>, which refers to the use of tissues or organs extracted from an organism but maintained viable under specific experimental conditions. Although isolated, these models retain part of the native environment\u2019s architecture and function, making them useful for more advanced physiological studies than classic in vitro models.<\/p>\n To preserve the original biological system\u2019s physiological, biochemical, and genetic characteristics, researchers often turn to human or animal cell cultures.<\/strong><\/a><\/p>\n These cultures simulate specific functions of tissues or organs and fall into four main types:<\/p>\n Primary cultures<\/strong>, derived directly from tissues.<\/p>\n<\/li>\n Secondary cultures,<\/strong> subcultures from primary ones.<\/p>\n<\/li>\n Continuous cell lines,<\/strong> which can divide indefinitely.<\/p>\n<\/li>\n Hybridomas,<\/strong> used for monoclonal antibody production.<\/p>\n<\/li>\n<\/ul>\n Drug evaluation with organ-on-chip systems<\/a>:<\/strong> Microfluidic devices that simulate key human functions (liver, gut, lung, etc.) using human cells, facilitating predictive efficacy and toxicity studies without animals.<\/p>\n<\/li>\n Regenerative medicine and tissue engineering:<\/strong> Using 3D cultures, bioreactors, or biofunctional scaffolds <\/a><\/strong>to study tissue regeneration, wound healing, or cell-matrix interactions.<\/p>\n<\/li>\n Assessment of dermal and transdermal absorption<\/strong> of cosmetic or pharmaceutical ingredients using reconstructed skin models or ex vivo tissues.<\/p>\n<\/li>\n Gastrointestinal digestion and metabolism studies:<\/strong> Using in vitro gut models<\/a><\/strong>, ex vivo tissues, or digestive simulators to analyse the stability and transformation of bioactive ingredients.<\/p>\n<\/li>\n Permeability and intestinal absorption models<\/strong> for ingredients, nutraceuticals, or food additives.<\/p>\n<\/li>\n Corrosion, irritation, and skin penetration testing<\/strong> in the development of chemical or cosmetic products, using validated models such as reconstructed human skin.<\/p>\n<\/li>\n Cleaning or disinfection tests<\/strong> on real tissues, useful in the healthcare or food sector.<\/p>\n<\/li>\n Validation of food preservation or processing technologies<\/strong>, such as pasteurisation or high-pressure treatments, on animal tissues.<\/p>\n<\/li>\n In vitro fertilisation (IVF)<\/strong>: One of the best-known examples, where fertilisation occurs outside the body in a lab dish, before transferring the embryo to the uterus.<\/p>\n<\/li>\n<\/ul>\n In vitro studies<\/strong> offer multiple advantages, making them essential tools for biomedical and pharmaceutical research.<\/p>\n They enable stricter experimental control<\/strong>, reducing interference from systemic variables and improving result reproducibility<\/strong> compared to in vivo models.<\/p>\n<\/li>\n The use of human tissues obtained through surgery or donation enhances physiological relevance and human applicability.<\/strong><\/p>\n<\/li>\n Non-invasive techniques can be integrated<\/strong>, allowing dynamic studies of cellular and tissue processes without compromising model viability.<\/p>\n<\/li>\n<\/ul>\n From an ethical standpoint<\/strong>, in vitro methods<\/strong> are a valid and preferred alternative to animal testing, aligned with the 3Rs principle (replacement, reduction, refinement)<\/strong>. This promotes the minimisation of animal use by substituting with alternative methods, reducing animal numbers, and improving experimental conditions to limit suffering.<\/p>\n However, these techniques also have limitations:<\/p>\n The lack of a global immune or systemic response<\/strong> limits the ability to replicate some complex biological interactions seen in whole organisms.<\/p>\n<\/li>\n Handling human tissues requires strict conservation and manipulation conditions<\/strong> to maintain their viability and functionality, which poses technical and logistical challenges.<\/p>\n<\/li>\n<\/ul>\n In vivo, ex vivo, and in vitro models<\/strong> should not be seen as mutually exclusive, but rather as complementary tools<\/strong> within the biomedical, technological, and applied research ecosystem. Each provides specific advantages depending on the study\u2019s objective, required complexity level, regulatory demands, or the type of compound or product being evaluated.<\/p>\n As scientific accuracy, ethical responsibility, and innovation efficiency take centre stage, in vitro testing is gaining prominence over animal models<\/strong>. While in vivo studies remain essential for exploring systemic responses, long-term toxicity, or complete pharmacokinetics, in vitro and ex vivo models offer more versatile, sustainable alternatives aligned with today\u2019s scientific and industrial challenges.<\/strong><\/p>\n This paradigm shift is supported by evolving regulatory frameworks that actively promote the use of alternative methods:<\/p>\n The EFSA<\/strong> encourages validated in vitro and mechanistic approaches<\/strong> for risk assessment.<\/p>\n<\/li>\n Under the EU REACH regulation<\/strong>, alternative methods are prioritised over animal testing in the chemical sector.<\/strong><\/p>\n<\/li>\n In the US<\/strong>, the FDA<\/strong> and other agencies have begun accepting data generated through advanced in vitro platforms<\/strong> in pharmacology and toxicology contexts.<\/p>\n<\/li>\n In Europe, the role of EURL ECVAM (European Union Reference Laboratory for Alternatives to Animal Testing)<\/strong> has been crucial in validating, harmonising, and promoting in vitro and alternative studies<\/strong>. This organisation not only assesses the scientific robustness of new methodologies but actively collaborates with regulatory agencies and international networks to facilitate regulatory acceptance and implementation across sectors such as cosmetics, medical devices, food, and industrial chemicals.<\/strong><\/p>\n<\/li>\n<\/ul>\n In sectors where ethical and regulatory requirements are particularly strict, such as cosmetics, functional foods, or nutraceuticals, in vitro and ex vivo studies are becoming key pillars of R&D&I innovation<\/strong>. Their ongoing development, coupled with regulatory support and the work of specialised institutions, signals a future in which biological relevance, sustainability, and ethical responsibility will become increasingly achievable.<\/p>\n Reference:<\/strong> EURL ECVAM. European Union Reference Laboratory for Alternatives to Animal Testing. European Commission Joint Research Centre (JRC). Available at: https:\/\/ec.europa.eu\/jrc\/en\/eurl\/ecvam<\/a> \u21a9<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/article>\nWhat Does In Vitro Mean?<\/h2>\n
\n
Common applications of in vivo studies<\/strong><\/h3>\n
\n
Advantages of in vivo testing<\/strong><\/h3>\n
\n
Limitations of in vivo testing<\/strong><\/h3>\n
\n
![\"White](\"https:\/\/www.ainia.com\/wp-content\/uploads\/2025\/07\/in-vivo-mouse-in-laboratory-environment-2025-02-11-06-57-54-utc-1-1024x683.jpg\")
<\/strong><\/h2>\nWhat Does In Vivo Mean?<\/h2>\n
In vitro or in vivo experiments: Use of cell cultures<\/strong><\/h3>\n
\n
Common applications of in vitro models<\/strong><\/h3>\n
\n
![\"Close-up](\"https:\/\/www.ainia.com\/wp-content\/uploads\/2025\/07\/science-and-biotechnology-laboratory-research-in-vitro-studies.jpg\")
<\/strong><\/h3>\nAdvantages of in vitro experiments<\/strong><\/h3>\n
\n
Limitations of in vitro <\/strong>experiments<\/strong><\/h3>\n
\n
In vitro or in vivo: Complementary approaches in research<\/strong><\/h2>\n
![\"Scientist](\"https:\/\/www.ainia.com\/wp-content\/uploads\/2025\/07\/experimentos-ex-vivo-foto-dos-1024x683.jpg\")
<\/strong><\/h3>\nWhen Are In Vitro and In Vivo Studies Used?<\/h2>\n
\n
\n\n\n\n\n\n\n\n